Efficacy and Safety of Letermovir for Cytomegalovirus Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s513383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Yongbing Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic …. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Antiviral Agents, Acetates. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
Zitieren
APA
Zhu, Y., Wang, L., Xiang, Y., Wang, Y., Zhang, A., Wang, Y., Yin, M., Dun, J., Xu, Y., Hu, Q., Yu, W., & Liu, A. (2025). Efficacy and Safety of Letermovir for Cytomegalovirus Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s513383
Vancouver
Zhu Y, Wang L, Xiang Y, Wang Y, Zhang A, Wang Y, et al. Efficacy and Safety of Letermovir for Cytomegalovirus Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s513383
BibTeX
@article{Zhu2025,
author = {Zhu, Yongbing and Wang, Li and Xiang, Yu and Wang, Yaqin and Zhang, Ai and Wang, Yao and Yin, Mengmeng and Dun, Jianxin and Xu, Yuting and Hu, Qun and Yu, Wen and Liu, Aiguo},
title = {Efficacy and Safety of Letermovir for Cytomegalovirus Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s513383}
}
EUVIMED